Comparative effectiveness of atogepant and rimegepant for migraine prevention in Japanese patients: an anchored matching-adjusted indirect comparison
Tsubasa Takizawa(Keio University), Mamoru Shibata(Tokyo Dental College Ichikawa General Hospital), Haris Jameel, Toru Yamazaki(AbbVie (United States)), Pranav Gandhi(AbbVie (United States)), Keisuke Suzuki(NEC (Japan)), Emma Tyas, Hisaka Igarashi(Fujitsu (Japan)), Noboru Imai(Shizuoka Red Cross Hospital), Judy Chen(Utrecht University), Naoko Sanno(Shinawatra University), Yoichiro Hashimoto(Saiseikai Kumamoto Hospital), Molly Duan(AbbVie (United States)), Ifeanyi Ubamadu(AbbVie (United States)), Gina Ahmadyar(AbbVie (United States))
Cited by 0
Related Papers
The role of gut hormones and the hypothalamus in appetite regulation
|Endocrine Journal|2010|315
Hallmarks of primary headache: part 1 – migraine
|The Journal of Headache and Pain|2024|174
Spreading depolarizations trigger caveolin‐1–dependent endothelial transcytosis
|Annals of Neurology|2018|107